These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32045)

  • 1. Binding of thioridazine and thioridazine metabolites to serum proteins in psychiatric patients.
    Nyberg G; Axelsson R; Mårtensson E
    Eur J Clin Pharmacol; 1978 Dec; 14(5):341-50. PubMed ID: 32045
    [No Abstract]   [Full Text] [Related]  

  • 2. Binding of thioridazine and some of its metabolites to human serum protein and human albumin.
    Belpaire FM; Vanderheeren FA; Bogaert MG
    Arzneimittelforschung; 1975; 25(12):1969-71. PubMed ID: 1243669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum concentration and elimination from serum of thioridazine in psychiatric patients.
    Axelsson R; Mårtensson E
    Curr Ther Res Clin Exp; 1976 Feb; 19(2):242-65. PubMed ID: 813963
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum concentration and protein binding of thioridazine and its metabolites in patients with chronic alcoholism.
    Axelsson R; Mårtensson E; Alling C
    Eur J Clin Pharmacol; 1982 Oct; 23(4):359-63. PubMed ID: 7173306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of thioridazine and thioridazine metabolites to serum proteins. An in vitro study.
    Nyberg G; Mårtensson E
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Jun; 319(3):189-96. PubMed ID: 7110380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid concentrations of thioridazine and its main metabolites in psychiatric patients.
    Nyberg G; Axelsson R; Mårtensson E
    Eur J Clin Pharmacol; 1981 Jan; 19(2):139-48. PubMed ID: 7202474
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma and red cell levels of thioridazine and clinical response in schizophrenia.
    Smith RC; Baumgartner R; Ravichandran GK; Shvartsburd A; Schoolar JC; Allen P; Johnson R
    Psychiatry Res; 1984 Aug; 12(4):287-96. PubMed ID: 6594712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albumin binding of thioridazine and some of its metabolites.
    Vandeheeren FA; Belpaire FM
    Arch Int Pharmacodyn Ther; 1975 Mar; 214(1):86-91. PubMed ID: 1171660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on thioridazine and mesoridazine metabolism. I. Protein binding.
    Forrest IS; Green DE; Blum A; Serra MT; Loeffler KO
    Commun Psychopharmacol; 1979; 3(5):319-22. PubMed ID: 548210
    [No Abstract]   [Full Text] [Related]  

  • 10. A fixed dose study of the plasma concentration and clinical effects of thioridazine and its major metabolites.
    Cohen BM; Lipinski JF; Waternaux C
    Psychopharmacology (Berl); 1989; 97(4):481-8. PubMed ID: 2498945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total plasma concentrations, red blood cell concentrations, and radioreceptor assay values compared with unbound plasma concentrations of thioridazine and thioridazine metabolites in psychiatric patients.
    Nyberg G; Svensson C; Olofsson U; Axelsson R; Mårtensson E
    Ther Drug Monit; 1987 Dec; 9(4):426-32. PubMed ID: 3424408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels and half lives of thioridazine and some of its metabolites. II. Low doses in older psychiatric patients.
    Muusze RG; Vanderheeren FA
    Eur J Clin Pharmacol; 1977 Jan; 11(2):141-7. PubMed ID: 837967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partitioning of thioridazine and mesoridazine in human blood fractions.
    Dinovo EC; Pollak H; Gottschalk LA
    Methods Find Exp Clin Pharmacol; 1984 Mar; 6(3):143-6. PubMed ID: 6748818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of thioridazine in psychiatric patients and healthy volunteers.
    Mårtensson E; Roos BE
    Eur J Clin Pharmacol; 1973 Oct; 6(3):181-6. PubMed ID: 4762056
    [No Abstract]   [Full Text] [Related]  

  • 15. [Interaction of atropine with blood serum proteins].
    Akopian OA
    Farmatsiia; 1974; 23(2):54-6. PubMed ID: 4136390
    [No Abstract]   [Full Text] [Related]  

  • 16. The binding of urate to plasma proteins determined by means of equilibrium dialysis.
    Klinenberg JR; Kippen I
    J Lab Clin Med; 1970 Mar; 75(3):503-10. PubMed ID: 5416905
    [No Abstract]   [Full Text] [Related]  

  • 17. Electrocardiographic changes and serum concentrations in thioridazine-treated patients.
    Axelsson R; Aspenstrom G
    J Clin Psychiatry; 1982 Aug; 43(8):332-5. PubMed ID: 7096274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thioridazine steady-state plasma concentrations are influenced by tobacco smoking and CYP2D6, but not by the CYP2C9 genotype.
    Berecz R; de la Rubia A; Dorado P; Fernández-Salguero P; Dahl ML; LLerena A
    Eur J Clin Pharmacol; 2003 May; 59(1):45-50. PubMed ID: 12682803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic blood levels and therapeutic effect.
    Cohen BM; Lipinski JF; Pope HG; Harris PQ; Altesman RI
    Psychopharmacology (Berl); 1980; 70(2):191-3. PubMed ID: 6107947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative determination of thioridazine and nonconjugated thioridazine metabolites in serum and urine of psychiatric patients.
    Mårtensson E; Nyberg G; Axelsson R; Serck-Hansen K
    Curr Ther Res Clin Exp; 1975 Nov; 18(5):687-700. PubMed ID: 812647
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.